Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR. Keever-Taylor CA, et al. Among authors: vesole dh. Biol Blood Marrow Transplant. 2001;7(11):620-30. doi: 10.1053/bbmt.2001.v7.pm11760150. Biol Blood Marrow Transplant. 2001. PMID: 11760150 Free article.
Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103.
Link CJ Jr, Burt RK, Traynor AE, Drobyski WR, Seregina T, Levy JP, Gordon L, Rosen ST, Burns WH, Camitta B, Casper J, Horowitz M, Juckett M, Lawton C, Margolis D, Pietryga D, Rowlings P, Taylor C, Furtado M, Stefka J, Gupta-Burt S, Kaiser H, Vesole DH. Link CJ Jr, et al. Among authors: vesole dh. Hum Gene Ther. 1998 Jan 1;9(1):115-34. doi: 10.1089/hum.1998.9.1-115. Hum Gene Ther. 1998. PMID: 9458247
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. Burns LJ, et al. Among authors: vesole dh. Bone Marrow Transplant. 2003 Jul;32(2):177-86. doi: 10.1038/sj.bmt.1704086. Bone Marrow Transplant. 2003. PMID: 12838283 Clinical Trial.
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.
Reece DE, Bredeson C, Pérez WS, Jagannath S, Zhang MJ, Ballen KK, Elfenbein GJ, Freytes CO, Gale RP, Gertz MA, Gibson J, Giralt SA, Keating A, Kyle RA, Maharaj D, Marcellus D, McCarthy PL, Milone GA, Nimer SD, Pavlovsky S, To LB, Weisdorf DJ, Wiernik PH, Wingard JR, Vesole DH. Reece DE, et al. Among authors: vesole dh. Bone Marrow Transplant. 2003 Dec;32(12):1135-43. doi: 10.1038/sj.bmt.1704288. Bone Marrow Transplant. 2003. PMID: 14647267 Review.
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.
Phillips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J, Fenton R, Filicko J, Grosso D, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Nath R, Reed E, Rapoport AP, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Phillips GL, et al. Among authors: vesole dh. Biol Blood Marrow Transplant. 2004 Jul;10(7):473-83. doi: 10.1016/j.bbmt.2004.03.001. Biol Blood Marrow Transplant. 2004. PMID: 15205668 Free article. Clinical Trial.
213 results